Sign In
Buy LNDC
$6.66
+0 (+0%)
At Close: Apr 12, 2023
NEW YORK , May 13, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Lifecore Biomedical In
NEW YORK , May 5, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Lifecore Biomedical Inc
NEW YORK , April 29, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Lifecore Biomedical
NEW YORK , April 19, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Lifecore Biomedical
NEW YORK , April 12, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Lifecore Biome
Landec Corporation (LNDC) Q1 2023 Earnings Call Transcript
10:40am, Thursday, 06'th Oct 2022
Landec Corporation (NASDAQ:LNDC ) Q1 2023 Earnings Conference Call October 6, 2022 8:00 AM ET Company Participants Jeff Sonnek - Investor Relations, ICR Jim Hall - Chief Executive Officer John Morberg
Landec (LNDC) Reports Q1 Loss, Tops Revenue Estimates
09:47am, Thursday, 06'th Oct 2022
Landec (LNDC) delivered earnings and revenue surprises of -166.67% and 1.89%, respectively, for the quarter ended August 2022. Do the numbers hold clues to what lies ahead for the stock?
Landec Corporation Revises First Quarter 2023 Earnings Conference Call for October 6, 2022 at 8:00 a.m. ET
04:05pm, Wednesday, 28'th Sep 2022
SANTA MARIA, Calif. and MINNEAPOLIS, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its
Landec Corporation Sets First Quarter 2023 Earnings Conference Call for October 5, 2022 at 2:00 p.m. PT
08:00am, Wednesday, 21'st Sep 2022
SANTA MARIA, Calif. and MINNEAPOLIS, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (“Landec” or the “Company”), a diversified health and wellness company focused on its
7 Small-Cap Stocks to Buy Before September Ends
11:54am, Thursday, 15'th Sep 2022
While broader markets face continued pressure amid recession fears, small-cap stocks stand out as an undervalued segment of the stock market. The Russell 2000 index, the popular benchmark for small-c
7 Small-Cap Stocks to Buy Before September Ends
02:40pm, Wednesday, 14'th Sep 2022
While broader markets face continued pressure amid recession fears, small-cap stocks stand out as an undervalued segment of the stock market. The Russell 2000 index, the popular benchmark for small-c
Landec Corporation (LNDC) CEO Jim Hall on Q4 2022 Results - Earnings Call Transcript
08:06pm, Wednesday, 10'th Aug 2022
Landec Corporation (NASDAQ:LNDC ) Q4 2022 Earnings Conference Call August 10, 2022 5:00 PM ET Company Participants Jeff Sonnek - Investor Relations, ICR Jim Hall - Chief Executive Officer John Morberg
7 Small-Cap Stocks to Buy in July 2022
08:15am, Monday, 04'th Jul 2022
These are the best small-cap stocks to buy for July 2022. ARCH, AVUV, CEIX, COUR, DVAX, FATE, and TENB can make great investments.
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
02:16pm, Wednesday, 06'th Apr 2022 Benzinga
Upgrades
According to Morgan Stanley, the prior rating for Royalty Pharma PLC (NASDAQ:RPRX) was changed from Equal-Weight to Overweight. In the fourth quarter, Royalty Pharma showed an EPS of $0.80, c
Landec Corporation (LNDC) CEO Albert Bolles on Q3 2022 Results - Earnings Call Transcript
10:25pm, Tuesday, 05'th Apr 2022
Landec Corporation (LNDC) CEO Albert Bolles on Q3 2022 Results - Earnings Call Transcript
